Valuation: Tianjin Ringpu Bio-Technology Co.,Ltd.

Capitalization 795.53Cr 117.25Cr 100.44Cr 92Cr 87Cr 161.02Cr 11TCr 162.32Cr 1.1TCr 425.73Cr 5.33TCr 440Cr 430.61Cr 19TCr P/E ratio 2026 *
19.1x
P/E ratio 2027 * 15.1x
Enterprise value 847.5Cr 124.91Cr 107.01Cr 98Cr 93Cr 171.54Cr 12TCr 172.92Cr 1.17TCr 453.55Cr 5.68TCr 468.75Cr 458.74Cr 20TCr EV / Sales 2026 *
2.26x
EV / Sales 2027 * 1.93x
Free-Float
51.84%
Yield 2026 *
1.71%
Yield 2027 * 2.74%
27/04 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
30/03 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
30/03 Tianjin Ringpu Bio-Technology Co.,Ltd. announces Annual dividend, payable on May 13, 2026 CI
27/03 Tianjin Ringpu Bio-Technology Co.,Ltd. announced that it expects to receive CNY 300 million in funding CI
28/11 Ringpu Bio-Technology Secures Registration For Feline Vaccine MT
30/25/30 Maxhealth Biotech Co. Ltd. announced that it has received CNY 400 million in funding from IDG Ventures, Shenzhen Capital Group Co., Ltd., Tianjin Ringpu Bio-Technology Co.,Ltd. CI
24/25/24 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25/25/25 Tianjin Ringpu Bio-Technology Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
14/25/14 Ringpu Bio-Tech Forecasts Up to 70% Rise in H1 Profit MT
14/25/14 Jiangxi Twins Biotechnology Co., Ltd signed a letter of intent to acquire 67.18% stake in Hunan Sinoland Bio-Pharmacy Co., Ltd. from Tianjin Ringpu Bio-Technology Co.,Ltd. and Jingpeng Holding Group Co., Ltd for approximately CNY 115 million. CI
30/25/30 Tranche Update on Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback Plan announced on November 4, 2024. CI
30/25/30 Tianjin Ringpu Bio-Technology Co.,Ltd.'s Equity Buyback announced on November 4, 2024, has closed with 6,997,751 shares, representing 1.52% for CNY 129.98 million. CI
26/25/26 Tianjin Ringpu Bio-Technology Co.,Ltd. Approves Cash Dividend on A Shares for the Year 2024, Payable on 21 May 2025 CI
1 day-2.18%
1 week-1.96%
Current month-2.67%
1 month-2.67%
3 months-7.50%
6 months-15.93%
Current year-6.66%
1 week 17.4
Extreme 17.4
18.31
1 month 17.4
Extreme 17.4
19.13
Current year 17.02
Extreme 17.02
21.51
1 year 17.02
Extreme 17.02
28.9
3 years 11.25
Extreme 11.25
28.9
5 years 11.25
Extreme 11.25
44.41
10 years 6.3
Extreme 6.3
44.41
Manager TitleAgeSince
Chief Executive Officer 53 30/03/2023
Director of Finance/CFO 51 28/04/2022
Corporate Officer/Principal 45 27/10/2020
Director TitleAgeSince
Chairman 63 12/05/2008
Director/Board Member 37 15/12/2025
Director/Board Member 53 25/12/2019
Change 5d. change 1-year change 3-years change Capi.($)
-2.18%-1.96%-19.82%-10.84% 119.75Cr
+0.81%-14.37%-51.74%-59.34% 3.12TCr
+0.62%-8.39%+70.77%+147.13% 1.09TCr
-0.40%-1.64%+26.66%+54.48% 573.24Cr
+0.29%-7.57%+12.22%+9.79% 334.52Cr
-1.48%-4.50%+100.00%+23.78% 228.65Cr
+1.01%-3.21%-19.86%-8.64% 171.27Cr
+3.12%-15.41%+56.29%+153.19% 143.03Cr
-0.96%-2.57%+5.73%-47.90% 109.32Cr
-1.49%-0.68%-14.26%-41.28% 100.9Cr
Average -0.07%-11.27%+16.60%+22.04% 598.6Cr
Weighted average by Cap. +0.47%-21.98%-6.77%+4.17%

Financials

2026 *2027 *
Net sales 374.27Cr 55Cr 47Cr 43Cr 41Cr 76Cr 5.27TCr 76Cr 515.65Cr 200.29Cr 2.51TCr 207.01Cr 202.59Cr 8.72TCr 429.63Cr 63Cr 54Cr 50Cr 47Cr 87Cr 6.05TCr 88Cr 591.93Cr 229.92Cr 2.88TCr 237.63Cr 232.55Cr 10TCr
Net income 42Cr 6.26Cr 5.36Cr 4.9Cr 4.64Cr 8.6Cr 598.47Cr 8.67Cr 59Cr 23Cr 284.39Cr 23Cr 23Cr 989.86Cr 54Cr 7.94Cr 6.8Cr 6.22Cr 5.89Cr 11Cr 759.02Cr 11Cr 74Cr 29Cr 360.68Cr 30Cr 29Cr 1.26TCr
Net Debt 52Cr 7.66Cr 6.56Cr 6Cr 5.68Cr 11Cr 732.46Cr 11Cr 72Cr 28Cr 348.06Cr 29Cr 28Cr 1.21TCr 34Cr 5.05Cr 4.33Cr 3.96Cr 3.75Cr 6.94Cr 482.91Cr 6.99Cr 47Cr 18Cr 229.47Cr 19Cr 19Cr 798.72Cr
Logo Tianjin Ringpu Bio-Technology Co.,Ltd.
Tianjin Ringpu Bio-Technology Co Ltd is a China-based company serving the animal health industry. The Company's main business areas are the research and development, production and sales of veterinary biological products, veterinary pharmaceutical preparations (chemicals, traditional Chinese veterinary medicines, disinfectants, and others), veterinary raw materials, veterinary functional additives, and provision of overall prevention and control of animal diseases. The Company's products include pharmaceuticals, vaccines, disinfectants, cleaning agents, and functional additives for pigs, chickens, waterfowl, cattle, sheep and pets, and others.
Employees
2,803
Date Price Change Volume
14/26/14 17.52 ¥ -2.18% 37,03,112
13/26/13 17.91 ¥ +0.90% 77,47,700
12/26/12 17.75 ¥ -1.93% 43,44,500
11/26/11 18.10 ¥ +0.95% 52,71,950
08/26/08 17.93 ¥ +0.28% 30,94,011
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
17.52CNY
Average target price
21.81CNY
Spread / Average Target
+24.47%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300119 Stock